Cargando…

Identification reproducible microbiota biomarkers for the diagnosis of cirrhosis and hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is a malignant tumor with high incidence in China, which is mainly related to chronic hepatitis B (CHB) and liver cirrhosis (LC) caused by hepatitis B virus (HBV) infection. This study aimed to identify reproducible gut microbial biomarkers across Chinese population fo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Huarong, Wu, Junling, Liu, Yijuan, Zeng, Yongbin, Jiang, Zhiyu, Yan, Haidan, Lin, Jie, Zhou, Weixin, Ou, Qishui, Ao, Lu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030758/ https://www.ncbi.nlm.nih.gov/pubmed/36943499 http://dx.doi.org/10.1186/s13568-023-01539-6

Ejemplares similares

Emerging roles of bile acids in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma
por: Xun, Zhen, et al.
Publicado: (2023)

Microbiome analysis reveals universal diagnostic biomarkers for colorectal cancer across populations and technologies
por: Zhang, Huarong, et al.
Publicado: (2022)

Compartmentalisation of Hepatitis B virus X gene evolution in hepatocellular carcinoma microenvironment and the genotype-phenotype correlation of tumorigenicity in HBV-related patients with hepatocellular carcinoma
por: Fu, Ya, et al.
Publicado: (2022)

Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosis
por: Gurbuz, Berivan, et al.
Publicado: (2023)

Identification of New Biomarker for Prediction of Hepatocellular Carcinoma Development in Early-Stage Cirrhosis Patients
por: Ning, Gang, et al.
Publicado: (2021)

Identification of reproducible drug-resistance-related dysregulated genes in small-scale cancer cell line experiments
por: Ao, Lu, et al.
Publicado: (2015)

Highly accurate disease diagnosis and highly reproducible biomarker identification with PathFormer
por: Li, Fuhai, et al.
Publicado: (2023)

Toll‐like receptors, long non‐coding RNA NEAT1, and RIG‐I expression are associated with HBeAg‐positive chronic hepatitis B patients in the active phase
por: Zeng, Yongbin, et al.
Publicado: (2019)

Mutational characterization of HBV reverse transcriptase gene and the genotype-phenotype correlation of antiviral resistance among Chinese chronic hepatitis B patients
por: Fu, Ya, et al.
Publicado: (2020)

Identification of potential biomarkers for diagnosis of hepatocellular carcinoma
por: Liang, Xing-Hua, et al.
Publicado: (2022)

Liver cirrhosis contributes to the disorder of gut microbiota in patients with hepatocellular carcinoma
por: Zheng, Ruipeng, et al.
Publicado: (2020)

Serum cytoskeleton-associated protein 4 as a biomarker for the diagnosis of hepatocellular carcinoma
por: Wang, Yu, et al.
Publicado: (2018)

Novel breath biomarkers identification for early detection of hepatocellular carcinoma and cirrhosis using ML tools and GCMS
por: Ain Nazir, Noor ul, et al.
Publicado: (2023)

Biomarkers in Hepatocellular Carcinoma: Current Status and Future Perspectives
por: Pan, Yasi, et al.
Publicado: (2020)

Metabolism-Related Gene Pairs to Predict the Clinical Outcome and Molecular Characteristics of Early Hepatocellular Carcinoma
por: Wu, Junling, et al.
Publicado: (2022)

Adenosine Triphosphate in Serum as a Promising Biomarker for Differential Diagnosis of Hepatitis B Disease Progression
por: Lin, Caorui, et al.
Publicado: (2022)

Cell Differentiation Trajectory in Liver Cirrhosis Predicts Hepatocellular Carcinoma Prognosis and Reveals Potential Biomarkers for Progression of Liver Cirrhosis to Hepatocellular Carcinoma
por: He, Zhaobin, et al.
Publicado: (2022)

Cartilage oligomeric matrix protein as a non-invasive biomarker for diagnosis of hepatocellular carcinoma in patients with liver cirrhosis
por: Abdel-Azeez, Hala A, et al.
Publicado: (2022)

Identification of race-associated metabolite biomarkers for hepatocellular carcinoma in patients with liver cirrhosis and hepatitis C virus infection
por: Di Poto, Cristina, et al.
Publicado: (2018)

Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

Annexin A2 is not a good biomarker for hepatocellular carcinoma in cirrhosis
por: LIU, ZHIKUN, et al.
Publicado: (2013)

Immunohistochemical angiogenic biomarkers in hepatocellular carcinoma and cirrhosis: correlation with pathological features
por: Ribeiro, Osmar Damasceno, et al.
Publicado: (2016)

A Comparative Study of Serum Angiogenic Biomarkers in Cirrhosis and Hepatocellular Carcinoma
por: Pocino, Krizia, et al.
Publicado: (2021)

A genetic variant in the CD40 gene is related to HBV infection in the Chinese Han population
por: Wu, Wennan, et al.
Publicado: (2023)

Identification and Analysis of Gut Microbiota and Functional Metabolism in Decompensated Cirrhosis with Infection
por: Philips, Cyriac Abby, et al.
Publicado: (2023)

Serum-Derived Exosomal miR-140-5p as a Promising Biomarker for Differential Diagnosis of Anti-NMDAR Encephalitis With Viral Encephalitis
por: Liu, Xiaofeng, et al.
Publicado: (2022)

Kallistatin, a new and reliable biomarker for the diagnosis of liver cirrhosis
por: Cheng, Zhiyun, et al.
Publicado: (2015)

High mobility group box 3 as an emerging biomarker in diagnosis and prognosis of hepatocellular carcinoma
por: Zheng, Wenjie, et al.
Publicado: (2018)

Plasma Protein Biomarkers of Hepatocellular Carcinoma in HCV-Infected Alcoholic Patients with Cirrhosis
por: Ferrín, Gustavo, et al.
Publicado: (2015)

Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

Emerging role of mitochondria in response to HBV infection
por: Lin, Caorui, et al.
Publicado: (2022)

A qualitative signature for early diagnosis of hepatocellular carcinoma based on relative expression orderings
por: Ao, Lu, et al.
Publicado: (2018)

Identification and Validation of Novel Biomarkers for Hepatocellular Carcinoma, Liver Fibrosis/Cirrhosis and Chronic Hepatitis B via Transcriptome Sequencing Technology
por: Zhao, Dandan, et al.
Publicado: (2022)

Establishment of Real Time Allele Specific Locked Nucleic Acid Quantitative PCR for Detection of HBV YIDD (ATT) Mutation and Evaluation of Its Application
por: Zeng, Yongbin, et al.
Publicado: (2014)

The efficacy of addition of Tenofovir Disoproxil Fumarate to Peg-IFNα-2b is superior to the addition of Entecavir in HBeAg positive CHB patients with a poor response after 12 weeks of Peg-IFNα-2b treatment alone
por: Lin, Sheng, et al.
Publicado: (2020)

The progressive elevation of alpha fetoprotein for the diagnosis of hepatocellular carcinoma in patients with liver cirrhosis
por: Arrieta, Oscar, et al.
Publicado: (2007)

Exosome Cargos as Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Zeng, Yulai, et al.
Publicado: (2023)

A Circulating Long Noncoding RNA Panel Serves as a Diagnostic Marker for Hepatocellular Carcinoma
por: Huang, Jinlan, et al.
Publicado: (2020)

Identification and Analysis of the Blood lncRNA Signature for Liver Cirrhosis and Hepatocellular Carcinoma
por: Xia, Qi, et al.
Publicado: (2020)

Screening and Identification of Potential Biomarkers in Hepatitis B Virus-Related Hepatocellular Carcinoma by Bioinformatics Analysis
por: Zeng, Xian-Chang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_lifsahnp7v5nq8jn5ulenboqj4